Proxy Votes Now

Home › Funds › Vanguard › Vanguard Explorer Fund

Vanguard Explorer Fund (VEXPX) proxy voting record 2023-2024

Fund family: Vanguard · Filed by VANGUARD EXPLORER FUND (CIK 34066) · SEC series S000002578

Share classes and tickers: VEXPX (C000007081), VEXRX (C000007082)

2023-20242024-20252025-2026

“With management” uses the answer Form N-PX asks for on every vote (Item 1(l)): whether the vote went with or against management’s recommendation, read from the records of the way the fund voted, and only where the filer’s records pass the site’s consistency check: 6,082 with, 246 against, 0 abstentions (in the total, not counted as with management); 12 votes not determined (12 where the filing records no recommendation); 59 split votes are in neither count. Shareholder proposals: 25 FOR, 41 AGAINST, 1 abstained, by the filing’s own vote-source field.

Compared with Vanguard as a whole

The same two figures as Vanguard’s manager page (1,142,958 ballot items across 129 funds and accounts), counted the same way for this fund.

2023-2024This fundItemsVanguardItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)96.6%6,04894.6%881,562
Backed environmental and social shareholder proposals at US companiesn/a272.9%11,493

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections4,363156
Say-on-Pay76328
Audit-related7220
Compensation24817
Corporate Governance22429
Capital Structure973
Shareholder Rights and Defenses328
Extraordinary Transactions271
Other Social Issues121
Environment or Climate112

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
VERTIV HOLDINGS CO.June 19, 2024$312M130
MEDPACE HOLDINGS INC.May 17, 2024$280M70
KIRBY CORP.April 26, 2024$252M50
RYDER SYSTEM INC.May 3, 2024$229M151
VIAVI SOLUTIONS INC.November 8, 2023$214M140
FLOWSERVE CORP.May 16, 2024$214M150
HOULIHAN LOKEY INC.September 20, 2023$210M111
REVOLUTION MEDICINES INC.November 8, 2023$206M31

Notable votes against management

MeetingCompanyProposalFundMgmt
May 3, 2024RYDER SYSTEM INC.To vote, on an advisory basis, on a shareholder proposal regarding the Company's climate change strategy and related impacts on employment. Shareholder proposalForAgainst
September 20, 2023HOULIHAN LOKEY INC.To amend and restate our amended and restated certificate of incorporation to provide exculpation from liability for certain officers to the extent permitted by the Delaware General Corporate Law (the "DGCL"), eliminate inoperative or historical provisions, and update certain other related miscellaneous provisions;AgainstFor
November 8, 2023REVOLUTION MEDICINES INC.To approve the issuance of shares of Revolution Medicines common stock (including securities convertible into or exercisable for shares of Revolution Medicines common stock) to certain equityholders of EQRx, Inc., which is referred to as EQRx, pursuant to the Agreement and Plan of Merger, dated as of July 31, 2023 (as it may be amended from time to time), by and among Revolution Medicines, Equinox Merger Sub I, Inc., Equinox Merger Sub II LLC, and EQRx, which proposal is referred to as the Revolution Medicines share issuance proposal.AgainstFor
June 13, 2024MONOLITHIC POWER SYSTEMS INC.Vote on a stockholder proposal to elect each director annually. Shareholder proposalForAgainst
June 13, 2024LIVE NATION ENTERTAINMENT INC.To hold an advisory vote on the company's executive compensation;AgainstFor
June 20, 2024OKTA INC.To elect three Class I directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Michael StankeyWithholdFor
January 24, 2024ACUITY BRANDS INC.Election of Director: Mary A. WinstonAgainstFor
May 1, 2024FLUOR CORP.Election of Director: H. Paulett EberhartAgainstFor
May 15, 2024CINEMARK HOLDINGS INC.Election Of Class II Director For A Term That Expires In 2027: Carlos SepulvedaWithholdFor
June 5, 2024GLOBUS MEDICAL INC.The approval of the amendment to the 2021 Equity Incentive Plan.AgainstFor
June 5, 2024GLOBUS MEDICAL INC.The approval of the amendment to the 2021 Equity Incentive Plan;AgainstFor
April 24, 2024LEVI STRAUSS & CO.The election as Class II directors of the four nominees named in the Proxy Statement: Jenny MingWithholdFor

Contested meetings

Meetings with a proxy contest or competing nominees (2 in 2023-2024), and how the fund voted the items on its ballot.

Every vote, 2023-2024

The vote-by-vote list is kept for the latest season, 2025-2026. Every vote of 2023-2024 is in the interactive database, company by company, under Vanguard.

About this fund’s record

In the 2023-2024 proxy season, Vanguard Explorer Fund (VEXPX) voted at 716 shareholder meetings of 695 companies, on 6,510 ballot items in all. On the 6,328 items where its filing records whether the vote went with or against management's recommendation, the fund voted with management on 96.1% and against it 246 times. Its most frequent area of disagreement was director elections (156 of its votes against management). It voted FOR 37.9% of the 66 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Vanguard's funds as a whole (96.6% against 94.6%). 2 of its meetings were contested.

About this page

Correction (20 November 2026): Until this date, the “votes against management” figures on /trends and on fund pages were miscounted. Form N-PX asks each fund to record whether each vote was for or against management’s recommendation; we had read that field as the recommendation itself. So a fund voting against a shareholder proposal, as the board recommended, was counted as voting against management, and a vote against a board nominee was counted as with management. Figures now use the field as the form defines it, only for filers whose records pass our consistency check; other votes show as “not determined”. Example: mega caps, 2026: 16.4% before, 8.6% now. Vanguard 500 Index: 67.2% with management before, 97.5% now.

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 20, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.